Navigation Links
Digital Health Startup FareWell Announces Key Hires as it Launches its Enterprise Offering Aimed at Reversing Chronic Disease in the Workplace
Date:8/8/2017

FareWell, a startup developing digital therapeutics to treat and reverse diabetes and heart disease, today announced two key additions to its executive team.

Penny Moore and Sachin Kelkar join an esteemed team of leaders and advisors in a San Francisco-based startup focused on reversing chronic disease in the workplace to improve the health of American workers and competitiveness of their employers.

Penny Moore joins FareWell as Head of Enterprise. Penny is an accomplished growth strategist who served as Chief Growth Officer at Kurbo Health, focused on childhood obesity, and ShapeUp, which delivered social wellness programs to employers and insurance companies around the world, before being acquired by Virgin Pulse in 2016. She also held leadership roles at Kaiser Permanente, UnitedHealthcare, and Aetna. Penny received a B.S. Pharmacy degree from the University of Missouri-Kansas City and a Certified Health Insurance Executive (CHIE) accreditation from AHIP.

Sachin Kelkar joins FareWell as Head of Finance and Corporate Development. Sachin is a seasoned finance and corporate development executive, most recently serving as Senior Vice President of Strategy and Corporate Development at Practice Fusion. Sachin fostered his passion to transform healthcare as Co-founder of LifeTech Capital, an advisory firm focused on bringing innovative biotech and medtech companies to market. He holds a B.A. from UC Berkeley and an MBA from the University of Chicago Booth School of Business.

“Penny and Sachin are excellent additions to our team. They are passionate about our mission to treat and reverse chronic disease, and they have unique experiences and key relationships to help us build and accelerate growth,” said CEO and Co-founder Kevin Appelbaum. “As we lead the second wave of innovation in digital therapeutics - focusing on disease reversal - FareWell will continue to attract and add more exceptional members to the team.”

FareWell’s Vision and Visionaries

FareWell is developing digital therapeutics to become first line treatments for type II diabetes, heart disease, and other chronic conditions, displacing medications and improving quality of life for employee populations. FareWell’s leadership team also includes an advisory board of industry luminaries led by Chief Science Officer and Advisory Board Chair, Dr. David Katz.

“We’ve known what it takes to prevent roughly 80% of all premature death, and the chronic diseases that precede it, for well over 20 years. The focus now must be on how - and FareWell is about how,” said Chief Science Officer Dr. David Katz. “Treating and reversing chronic disease through digital therapeutics requires cutting-edge technical know-how and clinical support, coupled with expertise in lifestyle medicine, nutrition, behavioral science, health coaching, and culinary education.”

Employers need FareWell

-The total cost of healthcare in the US is $3.2 trillion with treatment of chronic disease making up almost a third of that spend according to the CDC.

-Increases in healthcare spending are not leading to a decline in chronic disease.

-Almost half of these health care costs are paid by self-insured employers and employee contributions.

-A 10% decrease in costs of treating preventable diseases could unlock $70 billion a year in value in addition to benefits that can’t be measured in dollars.

“We view ourselves as partners to our employer customers and work to align our incentives with their benefits strategy through value-based pricing. This means we are paid for delivering outcomes that result in measurable cost savings, not per-member-per-month or other similar types of participation fees,” said CEO and Co-Founder Kevin Appelbaum. “This is game-changing for employers who want to see effective results for their employees and dependents in the short term and good health in the long term as they gain health literacy that transfers into the home and ultimately benefits entire families.”

FareWell Partners Benefit from Talent and Technology

The FareWell digital therapeutics platform leverages the latest in predictive analytics and AI technology. Participant outcomes can be predicted based on current engagement patterns, which allows coaches to adjust support at the individual level. This tech-powered medical intervention can be scaled to serve large populations through artificial intelligence and machine learning algorithms.

“FareWell’s digital tools and proprietary curriculum have proven to drive high engagement. Together with our best-in-class coaches with deep knowledge in nutrition and behavior change, participants learn skills that last a lifetime,” said Head of Health Dr. Mark Berman. “Drugs should not be the starting point. You can reverse chronic disease through better diet and lifestyle choices.”

To join the FareWell team in reversing chronic disease through the latest innovation in digital therapeutics, please visit https://farewell.io/

About FareWell™
Founded in 2015, FareWell has raised $12.5M in funding from its Co-founder & Chairman, David Perry, and other individual investors. FareWell launched its first online lifestyle intervention program in June 2016. Today, its mission to reverse chronic disease through digital therapeutics is supported by a growing team of health experts and Advisory Board Members.

Please follow FareWell
https://www.facebook.com/TeamFareWell/
https://twitter.com/Team_FareWell
https://farewell.io/blog/

Read the full story at http://www.prweb.com/releases/2017/08/prweb14572672.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Firefly Wireless Digital Otoscopes and Wireless Dermatoscopes Take off in Telemedicine
2. McShane Insurance of Texas Announces Ground-Breaking Virtual Insurance Office and Digital Marketing Campaign
3. MDWebPro, Powered by Digital Solutions, Announces the Beginning of Local Search Month During November
4. HMP Communications Holdings, LLC Announces Pharmacy Learning Network Digital Expansion
5. The Award-Winning Documentary SEEKING HAPPILY EVER AFTER Announces Its Worldwide Digital Release
6. Global And China Digital Radiography Industry 2013 Deep Research Report
7. Digital Marketing Service For Plastic Surgery Sector Launched By Strategic Medica
8. Lampe-Batkin Associates Unveils Its New Custom Virtual Insurance Office and Digital Marketing Campaign
9. Finn’s JM&J Insurance Agency Unveils Custom Virtual Insurance Office and New Digital Marketing Campaign
10. SocialWellth™ and Validic Launch Unique Digital Experience for the “Quantified Self” Movement
11. CardioVet Introduces New Wireless Digital ECG Device to the Veterinary Market to Facilitate Cardiology Telemedicine Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 18, 2017 , ... ... a transparent, verifiable database to help the cannabis industry move towards greater legitimacy. ... to deliver a faster technology with lower fees. Paragon will build a fully ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the ... there are two sides. There are not two sides to hatred, bigotry, discrimination, and ... and prejudice, and the NPEIV stands against all forms of such hatred and discrimination ...
(Date:8/18/2017)... , ... August 18, 2017 , ... More than 20,000 ... Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions of ... the generous support of the Liberty community. These shoes will save lives from the ...
(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... , Aug. 17, 2017 Bio-Ess Laboratories, LLC Chief Science ... antibody titer and present new data on Cell-Ess® Universal Titer ... Boston, MA August 21-25.  The Bioprocessing Summit convenes ... bioprocess challenges. ... Optimizer ...
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology: